antibody type
|
percent of fluorescent light - emitting particles
|
---|
|
post - fasting
|
post - prandial
|
---|
anti-CD42bPE+ and anti-CD31FITC+
|
73%
|
70%
|
anti-CD235FITC+
|
18%
|
15%
|
anti-CD31FITC+ and anti-CD42bPE-
|
6%
|
6%
|
anti-CD42bPE- and anti-CD31FITC-
|
21%
|
24%
|
background
|
4,5%
|
9%
|
- Antibodies interact with platelet (CD42b), erythrocyte (CD235) or platelet/endothelial (CD31) surface molecules: anti-CD31-FITC and anti-CD42-PE positive events correspond to platelet - derived MVs, anti-CD235-FITC positive events correspond to erythrocyte - derived MVs, anti-CD31-FITC positive and anti-CD42b-PE negative events correspond to endothelial - derived MVs and double negative events with respect to anti-CD42b-PE and anti-CD31-FITC correspond to unstained particles in isolates consisting of background, membranous structures for which staining was unsuccessful and sample - derived non - membranous structures.